Published in J Clin Microbiol on September 01, 2000
Comparative and genetic analyses of the putative Vibrio cholerae lipopolysaccharide core oligosaccharide biosynthesis (wav) gene cluster. Infect Immun (2002) 1.25
Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review. Springerplus (2015) 1.10
Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria. Wien Klin Wochenschr (2007) 0.96
Fatal bacteremia due to immotile Vibrio cholerae serogroup O21 in Vientiane, Laos - a case report. Ann Clin Microbiol Antimicrob (2008) 0.83
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28
Non-O:1 Vibrio cholerae bacteremia: case report and review. Rev Infect Dis (1988) 2.07
[Distribution of serogroups of Vibrio cholerae non-O1 non-O139 with specific reference to their ability to produce cholera toxin, and addition of novel serogroups]. Kansenshogaku Zasshi (1997) 1.53
Non-O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol (1981) 1.35
Blood stream invasion by Vibrio cholerae O139. Lancet (1993) 1.26
Cytotoxin and enterotoxin production as factors delineating enteropathogenicity of Aeromonas caviae. J Clin Microbiol (1990) 1.24
Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center. Am J Gastroenterol (1996) 1.21
Nontoxigenic Vibrio cholerae 01 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India. J Clin Microbiol (1996) 1.20
Association of a disease approximating cholera caused by Vibrio cholerae of serogroups other than O1 and O139. Epidemiol Infect (1998) 1.15
Recurrent non-0:1 Vibrio cholerae bacteremia in a patient with multiple myeloma. Cancer (1993) 0.96
Primary septicemia caused by Vibrio cholerae non-O1 acquired on Cape Cod, Massachusetts. Clin Infect Dis (1995) 0.88
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A (1990) 3.25
Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol (1987) 3.16
Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature (1987) 2.85
The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol (1992) 1.95
Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol (1988) 1.92
Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A (1997) 1.78
The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol (1997) 1.48
The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol (1998) 1.45
Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc Natl Acad Sci U S A (1988) 1.41
Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem (1993) 1.36
Osteomyelitis in the patient with sickle-cell disease. J Bone Joint Surg Am (1971) 1.35
Internal fixation versus traction and casting of adolescent femoral shaft fractures. J Pediatr Orthop (1990) 1.28
Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides. Proc Natl Acad Sci U S A (1991) 1.20
The major antigen of elastin-associated microfibrils is a 31-kDa glycoprotein. J Biol Chem (1986) 1.20
Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol (1995) 1.18
The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity. J Trauma (1997) 1.16
Evaluation of ankle fractures: non-operative and operative treatment. Clin Orthop Relat Res (1979) 1.14
Complete amino acid sequence of staphylococcal enterotoxin A. J Biol Chem (1987) 1.08
Fixation of distal femoral fractures above total knee arthroplasty utilizing the Less Invasive Stabilization System (L.I.S.S.). Injury (2001) 1.07
Abiotrophia species as a cause of endophthalmitis following cataract extraction. J Clin Microbiol (1999) 1.06
Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc Natl Acad Sci U S A (1995) 1.04
Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. J Immunol (1994) 1.04
Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. J Immunol (1989) 1.01
The hepatitis nucleocapsid as a vaccine carrier moiety. Ann N Y Acad Sci (1995) 1.01
Current concepts and treatment of digitalis toxicity. Am J Cardiol (1971) 0.98
Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen. J Immunol (1990) 0.95
Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model. J Immunol (1994) 0.93
Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol (1995) 0.93
External fixation of femoral fractures. Indications and limitations. Clin Orthop Relat Res (1989) 0.93
Functional identification of agretopic and epitopic residues within an HBcAg T cell determinant. J Immunol (1989) 0.91
Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity. J Immunol (1990) 0.87
Evaluation of arrhythmias in the late hospital phase of acute myocardial infarction compared to coronary care unit ectopy. Br Heart J (1975) 0.86
Comminuted fractures of the proximal radius and ulna. Clin Orthop Relat Res (1993) 0.85
Consideration of the therapeutic roles of pharmacologic agents, collateral circulation and saphenous vein bypass in coronary artery disease. Am J Cardiol (1971) 0.85
Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris. Am J Cardiol (1974) 0.85
Production of interleukin-10 in human fracture soft-tissue hematomas. Shock (1996) 0.84
Tire explosion injuries. Orthopedics (1989) 0.82
Cunninghamella bertholletiae wound infection of probable nosocomial origin. South Med J (1981) 0.82
Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate. Biochim Biophys Acta (1991) 0.81
Biochemical and immunochemical evaluation of tissues and synovial fluid from patients undergoing total joint arthroplasty. Biomed Sci Instrum (1997) 0.81
Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts. Eur J Cell Biol (1990) 0.81
Fibrous capsule formation in response to ultrahigh molecular weight polyethylene treated with peptides that influence adhesion. Biomed Sci Instrum (1997) 0.80
Management of low velocity gunshot-induced fractures. J Orthop Trauma (1990) 0.80
Orthopedic management of knee dislocations. Comparison of surgical reconstruction and immobilization. Am J Knee Surg (1995) 0.80
Prevention of venous thromboembolism in Wales: results of a survey among general surgeons. Postgrad Med J (2002) 0.79
Pseudo-malignant lesions in Paget's disease of bone. Am J Roentgenol Radium Ther Nucl Med (1975) 0.79
Tibial plateau fractures. A review of operative treatment using AO technique. Orthopedics (1987) 0.78
The effects of growth hormone and insulin-like growth factor on the proliferation rate and morphology of RAW 264.7 macrophages. Biomed Sci Instrum (2000) 0.78
Pitfalls in the prenatal diagnosis of peroxisomal beta-oxidation defects by chorionic villus sampling. Prenat Diagn (1994) 0.77
Post-embedding methods for immunolocalization of elastin and related components in tissues. J Histochem Cytochem (1988) 0.77
Investigation of synthetic Escherichia coli heat-stable enterotoxin as an immunogen for swine and cattle. Infect Immun (1987) 0.77
Cleavage and deprotection of peptides on MBHA-resin with hydrogen bromide. Int J Pept Protein Res (1993) 0.76
The mechanical integrity of healed diaphyseal bone defects grafted with calcium hydroxyapatite/calcium triphosphate ceramic in a new animal model. Clin Mater (1990) 0.75
Radiology of bone grafts. Radiol Clin North Am (1975) 0.75
Operative management of ipsilateral fractures of the hip and femur. J Orthop Trauma (1988) 0.75
Beware of groin pain in the elderly athlete. Hosp Med (2001) 0.75
An evaluation of cefoxitin in the prevention of postoperative infections following orthopedic surgical procedures. Orthopedics (1985) 0.75
Phased-array optical scanning. Appl Opt (1979) 0.75
Audiometry. Nurs Times (1982) 0.75
Comparison of performance of final-year students from three Australian medical schools. Med J Aust (1987) 0.75
Femur fracture with ipsilateral knee dislocation. Orthopedics (1993) 0.75
Metallurgical evaluation of retrieved implants and correlation of failures to patient record data. Orthopedics (1989) 0.75
Anticholinergic hallucinosis. I. Effect of atropine and JB-329 on "caudate spindle" phenomena and electrical activity of cat hippocampus. Panel discussion. Recent Adv Biol Psychiatry (1965) 0.75
Retroviral-mediated transfer and expression of hepatitis B e antigen in human primary skin fibroblasts and Epstein-Barr virus-transformed B lymphocytes. Virology (1989) 0.75
Simple treatment for congenital eyelid eversion. Ophthalmic Surg (1984) 0.75
Torsional properties of healed canine diaphyseal defects grafted with a fibrillar collagen and hydroxyapatite/tricalcium phosphate composite. J Appl Biomater (1994) 0.75
Congenital vertical ocular motor apraxia. J Clin Neuroophthalmol (1985) 0.75
Cardiovascular activity of aromatic guanidine compounds. J Med Chem (1975) 0.75
Synthesis and peripheral vasodilator activity of -(1-(4-piperidylamino)alkyl)benzyl alcohols. J Med Chem (1971) 0.75
Clinical pathologic conference. Am Heart J (1971) 0.75
External fixation of the femur. Instr Course Lect (1990) 0.75
Wagner apparatus: a portable traction device for the femur. Instr Course Lect (1984) 0.75
Severe intravascular hemolysis after triple valve replacement: cure by replacement of aortic and mitral valves with porcine xenografts. Surgery (1979) 0.75
Development of sustained delivery system as a novel technique for tissue culture. Biomed Sci Instrum (2000) 0.75
Gunshot fractures. Unfallchirurg (1986) 0.75
Animals in medical research. Official statement of the American Thoracic Society. Am Rev Respir Dis (1991) 0.75
Differentiation of rare leukodystrophies by post-mortem morphological and biochemical studies: female adrenoleukodystrophy-like disease and late-onset Krabbe disease. Neuropediatrics (1996) 0.75
Management of angina pectoris. Therapeutic methods and physiologic mechanisms. Adv Cardiol (1974) 0.75
The William S. Hall psychiatric institute. J S C Med Assoc (1968) 0.75
Total replacement of the hip joint. Surg Annu (1973) 0.75